DB01269 ( vectibix ) . DB01269 ( Vectibix ) , is a human monoclonal antibody P00533 antagonist indicated as a single agent for the treatment of metastatic colorectal carcinoma with disease progression on or following fluoropyrimidine , oxaliplatin , and irinotecan chemotherapy regimens . This article will present the mechanism of action as well as the clinical role for this monoclonal antibody .